High- versus low-dose ACE inhibition in chronic heart failure
Authors:
- Dirk J van VeldhuisenDVDirk J van Veldhuisen
- Sabine Genth-ZotzSGSabine Genth-Zotz
- Jan BrouwerJBJan Brouwer
- Frans BoomsmaFBFrans Boomsma
- Tilo NetzerTNTilo Netzer
- Arie J Man In ’t VeldAVArie J Man In ’t Veld
- Yigal M PintoYPYigal M Pinto
- K.I LieKLK.I Lie
- Harry J.G.M CrijnsHCHarry J.G.M Crijns
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Large Differences in Drug Treatment of Chronic Heart Failure Between the European CountriesJACC, 1998
- Effects of angiotensin-converting enzyme inhibitor on plasma b-type natriuretic peptide levels in patients with acute myocardial infarctionJournal of Cardiac Failure, 1997
- Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice?JACC, 1996
- The Management of Chronic Heart FailureNew England Journal of Medicine, 1996
- Prolonging Action of Imidapril on the Lifespan Expectancy of Cardiomyopathic HamstersJournal of Cardiovascular Pharmacology, 1996
- ACE inhibitor co-therapy in patients with heart failure: Rationale for the Randomized Aldactone Evaluation Study (RALES)European Heart Journal, 1995
- Imidapril hydrochloride in essential hypertension: a double-blind comparative study using enalapril maleate as a controlJournal Of Hypertension, 1995
- ACE inhibitors for heart failure: a question of doseHeart, 1994
- Dose finding studies with imidapril—a new ACE inhibitor.British Journal of Clinical Pharmacology, 1994
- Pharmacological Studies on TA-6366, a New ACE Inhibitor: II. Effect of Long-Term Administration from the Pre-Hypertensive Stage on Blood Pressure, Relative Heart Weight and ACE Activity of Various Tissues in Spontaneously Hypertensive Rats(SHRs).The Japanese Journal of Pharmacology, 1991